AI Article Synopsis

  • Non-small cell lung cancer (NSCLC) commonly spreads to sites like the brain and liver, but small bowel metastasis is rare, especially in adenocarcinoma.
  • A 56-year-old adenocarcinoma patient was diagnosed with duodenal metastasis via FDG/PET-CT and biopsy, initially being asymptomatic.
  • He later experienced obstructive jaundice due to rapid disease progression, necessitating endoscopic biliary drainage, and responded positively to pembrolizumab treatment.

Article Abstract

Non-small cell lung cancer (NSCLC) is characterised by diffuse metastases, with common sites being the brain, liver, bones, and adrenal glands. Small bowel metastasis from NSCLC is a rare phenomenon, particularly in patients with an adenocarcinoma histology. We report the case of a 56-year-old lung adenocarcinoma patient with a duodenal metastasis diagnosed on FDG/PET-CT and confirmed on duodenal biopsy. Although initially asymptomatic, he subsequently presented with obstructive jaundice secondary to rapid local disease progression at the duodenal metastasis, requiring endoscopic intervention for biliary drainage. He was commenced on single agent pembrolizumab, with disease response on subsequent follow-up. This case highlights a rare case of gastrointestinal metastasis from NSCLC requiring endoscopic intervention due to rapid progression of the disease at the site of metastasis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506373PMC
http://dx.doi.org/10.1159/000508745DOI Listing

Publication Analysis

Top Keywords

duodenal metastasis
12
lung adenocarcinoma
8
metastasis nsclc
8
requiring endoscopic
8
endoscopic intervention
8
metastasis
6
pancreatitis biliary
4
biliary obstruction
4
obstruction secondary
4
duodenal
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!